J9297
HCPCSInj pemetrexed (sandoz) 10mg
Official HCPCS Level II long descriptor
Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
HCPCS Level II code J9297 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj pemetrexed (sandoz) 10mg
Added to HCPCS: 2023-04-01
Nearby codes in J9
- J9285Inj, olaratumab, 10 mg
- J9286Inj glofitamab gxbm, 2.5 mg
- J9289Inj nivolumab 2 mg hyaluron
- J9292Inj, pemetrexed dipotassium
- J9293Mitoxantrone hydrochl / 5 mg
- J9294Inj pemetrexed, hospira 10mg
- J9295Injection, necitumumab, 1 mg
- J9296Inj pemetrexed (accord) 10mg
- J9298Inj nivol relatlimab 3mg/1mg
- J9299Injection, nivolumab
- J9301Obinutuzumab inj
- J9302Ofatumumab injection
- J9303Panitumumab injection
- J9304Inj. pemetrexed, 10 mg
- J9305Inj. pemetrexed nos 10mg
- J9306Injection, pertuzumab, 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.